港股异动丨智美体育(1661.HK)涨19.64% 上调配售价
格隆汇2月16日丨智美体育(1661.HK)涨19.64%,报0.335港元,总市值5.34亿港元。智美体育公布,于2021年2月15日,配售代理与公司订立配售协议之补充协议,据此,配售代理及公司同意将配售价由每股配售股份0.232港元修订为每股配售股份0.235港元。股份于配售协议日期在联交所所报收市价每股0.28港元折让约16.07%。待配售事项完成后,预计配售事项之最高所得款项总额及所得款项净额(经扣除配售佣金以及其他相关成本及费用后)将分別约为74,868,274港元及72,622,226港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.